Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin [Internet]. 2024;74(3):229–63.

Article  PubMed  Google Scholar 

Vargas HA, Akin O, Zheng J, Moskowitz C, Soslow R, Abu-Rustum N, et al. The value of MR imaging when the site of uterine cancer origin is uncertain. Radiology [Internet]. 2011;258(3):785–92.

Article  PubMed  Google Scholar 

Bourgioti C, Chatoupis K, Panourgias E, Tzavara C, Sarris K, Rodolakis A, et al. Endometrial vs. cervical cancer: development and pilot testing of a magnetic resonance imaging (MRI) scoring system for predicting tumour origin of uterine carcinomas of indeterminate histology. Abdom Imaging [Internet]. 2015;40(7):2529–40.

Article  PubMed  Google Scholar 

Zaino RJ, Kurman R, Herbold D, Gliedman J, Bundy BN, Voet R, et al. The significance of squamous differentiation in endometrial carcinoma. Data from a Gynecologic Oncology Group study. Cancer [Internet]. 1991;68(10):2293–302.

Article  CAS  PubMed  Google Scholar 

McCluggage WG. Endocervical glandular lesions: controversial aspects and ancillary techniques. J Clin Pathol [Internet]. 2003;56(3):164–73.

Article  CAS  PubMed  Google Scholar 

Staebler A, Sherman ME, Zaino RJ, Ronnett BM. Hormone receptor immunohistochemistry and human papillomavirus in situ hybridisation are useful for distinguishing endocervical and endometrial adenocarcinomas. Am J Surg Pathol [Internet]. 2002;26(8):998–1006.

Article  PubMed  Google Scholar 

Kong CS, Beck AH, Longacre TA. A panel of 3 markers, including p16, ProExC, or HPV ISH, is optimal for distinguishing between primary endometrial and endocervical adenocarcinomas. Am J Surg Pathol [Internet]. 2010;34(7):915–26.

Article  PubMed  PubMed Central  Google Scholar 

Liao C-L, Lee M-Y, Tyan Y-S, Kok L-F, Wu TS, Koo C-L, et al. Progesterone receptor does not improve the performance and test effectiveness of the conventional 3-marker panel, consisting of estrogen receptor, vimentin, and carcinoembryonic antigen in distinguishing between primary endocervical and endometrial adenocarcinomas in a tissue microarray extension study. J Transl Med [Internet]. 2009;7(1):37.

Article  PubMed  Google Scholar 

Kamoi S, AlJuboury MI, Akin M-R, Silverberg SG. Immunohistochemical staining in the distinction between primary endometrial and endocervical adenocarcinomas: another viewpoint. Int J Gynecol Pathol [Internet]. 2002;21(3):217–23.

Article  PubMed  Google Scholar 

Cibula D, Pötter R, Planchamp F, Avall-Lundqvist E, Fischerova D, Haie Meder C, et al. The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology guidelines for managing patients with cervical cancer. Int J Gynecol Cancer [Internet]. 2018;28(4):641–55.

Article  PubMed  Google Scholar 

Concin N, Matias-Guiu X, Vergote I, Cibula D, Mirza MR, Marnitz S, et al. ESGO/ESTRO/ESP guidelines for managing patients with endometrial carcinoma. Int J Gynecol Cancer [Internet]. 2021;31(1):12–39.

Article  PubMed  Google Scholar 

He H, Bhosale P, Wei W, Ramalingam P, Iyer R. MRI is particular in determining primary cervical versus endometrial cancer when inconclusive biopsy results. Clin Radiol [Internet]. 2013;68(11):1107–13.

Article  CAS  PubMed  Google Scholar 

Haider MA, Patlas M, Jhaveri K, Chapman W, Fyles A, Rosen B. Adenocarcinoma involving the uterine cervix: magnetic resonance imaging findings in endometrial tumours, compared with cervical origin. Can Assoc Radiol J. 2006;57(1):43–8.

PubMed  Google Scholar